Deeter Investments
YARW

Deeter Investments’s Yarrow Bioscience YARW Stock Holding History

Deeter Investments’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Hold
20,000
– – 0.09% 89
2026
Q1 		$598K Hold
20,000
– – 0.07% 90
2025
Q4 		$580K Buy
+20,000
New +$401K 0.12% 70

Other funds holding YARW

ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Shay Capital
Shay Capital New York $1.56B AUM 46.14% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Braidwell
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KVP Capital Advisors
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Deeter Investments's YARW Position: Q2 2026 in Review

Deeter Investments held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 20,000 shares worth $651K. The position accounts for 0.09% of the portfolio, ranked #89.

Deeter Investments first reported a position in YARW in Q4 2025 and has held it in 3 quarters since. 41 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Deeter Investments held 20,000 shares of Yarrow Bioscience worth $651K as of Q2 2026.
  • Deeter Investments left its Yarrow Bioscience share count unchanged in Q2 2026.
  • Yarrow Bioscience made up 0.09% of Deeter Investments's portfolio in Q2 2026, its #89 holding.
  • Deeter Investments first reported a position in Yarrow Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 41 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Deeter Investments's 13F filing for Q2 2026, filed 8 Oct 2026.